racemetirosine has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakashima, K; Nakaso, K; Yoshimoto, Y | 1 |
| Kerk, S; Meng Lim, T; Zhou, Z | 1 |
2 other study(ies) available for racemetirosine and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells.
Topics: alpha-Methyltyrosine; Animals; Cathepsin B; Cell Survival; Dopamine; Leupeptins; Levodopa; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Tyrosine 3-Monooxygenase; Ubiquitin | 2005 |
Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132.
Topics: alpha-Methyltyrosine; Animals; Cell Survival; Cysteine Proteinase Inhibitors; Dopamine; Leupeptins; Malondialdehyde; Mice; Neurodegenerative Diseases; Neurons; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Tetrazolium Salts; Thiazoles | 2008 |